| abstract |
Disclosed is a crystalline form of the hydrochloride or hydrobromide salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinoline-carboxamide, which has excellent characteristics in terms of physical properties and pharmacokinetics, particularly dissolution rate and bioavailability, and thus is useful as an angiogenesis inhibitor or c-Kit kinase inhibitor. |